BackNatureWise Biotech & Medicals Overview

NatureWise Biotech & Medicals Current Assets

Latest current assets for 4732.TWO: $580M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$577.43M
↓ 19.79% YoYΔ $-142.50M vs prior year quarter

Peer trimmed avg / median

Loading

NatureWise Biotech & Medicals Current Assets History

Loading

NatureWise Biotech & Medicals vs. peers: Current Assets Comparison

Loading

NatureWise Biotech & Medicals Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

NatureWise Biotech & Medicals (4732.TWO) FAQ

As of the most recent data (June 2026), 4732.TWO shows a current assets of $580M. That compares with $720M in the prior-year period — down 19.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 4732.TWO's current assets is now $580M (was $720M) — a 19.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether NatureWise Biotech & Medicals is outperforming or lagging.

Tracking 4732.TWO's current assets over time shows whether NatureWise Biotech & Medicals is scaling, shrinking, or reshaping that part of the business. The current reading is $580M That compares with $720M in the prior-year period — down 19.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has NatureWise Biotech & Medicals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $580M) with ownership activity and broader fundamentals.

NatureWise Biotech & Medicals's current assets is $580M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.